Dr. Ray W. Shepherd, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 270
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
VA license 0101056291 -
Critical Care Medicine (Internal Medicine) Physician
VA license 0101056291 -
Internal Medicine Physician
VA license 0101056291
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Medical College of Virginia Hospitals Richmond, VA
- Vcu Health Tappahannock Hospital Tappahannock, VA
- Community Memorial Hospital South Hill, VA
Medical groups
- Mcv Associated Physicians (1,807 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 270
- Services billed
- 534
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 139 | 95 |
| Aspiration of fluid from chest cavity using imaging guidance | 40 | 35 |
| Established patient office or other outpatient visit, 20-29 minutes | 30 | 26 |
| New patient office or other outpatient visit, 45-59 minutes | 30 | 30 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 13 | 11 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Richmond, VA | 70 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Richmond, VA | 60 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Richmond, VA | 58 |
| Prednisone Other prescribers in Richmond, VA | 48 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Richmond, VA | 48 |
| Ipratropium Bromide Other prescribers in Richmond, VA | 31 |
| Montelukast Sodium Other prescribers in Richmond, VA | 27 |
| Azithromycin Other prescribers in Richmond, VA | 22 |
| Fluticasone Propionate Other prescribers in Richmond, VA | 20 |
| Stiolto Respimat (tiotropium br/olodaterol hcl) Other prescribers in Richmond, VA | 19 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $53.97 in total to this clinician.
| United Therapeutics Corporation | $53.97 |
|---|
| Food and Beverage | $53.97 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $31,077 in research payments for these studies, mostly to the institutions running them.
- CS006 RHEOX PIVOTAL
Galvanize Therapeutics, Inc
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.